Icon

BRIDION (nda022225)- (EQ 500MG BASE/5ML (EQ 100MG BASE/ML),EQ 200MG BASE/2ML (EQ 100MG BASE/ML))

SUGAMMADEX SODIUM MSD SUB MERCK
EQ 500MG BASE/5ML (EQ 100MG BASE/ML),EQ 200MG BASE/2ML (EQ 100MG BASE/ML)
Yes No
2026-Jan-27 2020-Dec-15
None None
None No
BRIDION is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults and pediatric patients aged 2 years and older undergoing surgery.
4 6 1
Total Other Developers 32
Drugs with Suitability No
EQ 500MG BASE/5ML (EQ 100MG BASE/ML) ** ** - - -
EQ 200MG BASE/2ML (EQ 100MG BASE/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** ****** ****** ******* *********** ****** **. ***, ******* ****, ***** ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.